- Report
- October 2024
- 181 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- December 2024
- 175 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Report
- January 2022
- 218 Pages
Global
From €4368EUR$4,799USD£3,744GBP
- Report
- December 2023
- 150 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- February 2024
- 75 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2021
- 545 Pages
Global
From €3640EUR$4,000USD£3,121GBP
The DNA Sequencer market is a subset of the larger Genomics market, which focuses on the study of the structure, function, and evolution of genomes. DNA Sequencers are used to analyze and sequence DNA, which is the genetic material of living organisms. This technology is used in a variety of applications, such as gene expression analysis, genetic variation analysis, and genome sequencing.
DNA Sequencers are used in a variety of industries, including healthcare, agriculture, and research. In healthcare, they are used to diagnose and treat genetic diseases, while in agriculture, they are used to improve crop yields and reduce the risk of disease. In research, they are used to study the genetic basis of diseases and to develop new treatments.
The DNA Sequencer market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Oxford Nanopore Technologies, Pacific Biosciences, and QIAGEN. Show Less Read more
